Twitter

Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)

Condition:   Leukemia, Myeloid, Acute
Intervention:   Drug: Volasertib
Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals
Recruiting – verified August 2012

Read the original: Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)




Comments are closed.